Getting to know Noxopharm and their approach to human degenerative disease

Thought Leader:

Dr. Graham Kelly, CEO and Managing Director, Noxopharm

November 5, 2021

In this episode, Dr. Graham Kelly talks about the history of Noxopharm and some of their groundbreaking work in drug discovery and development. Learn about their focus on human degenerative disease and their novel approach to therapies in this area.

Length: 13:48       Size: 6MB

Post a Comment

You must be logged in to post a Comment.